Therapeutic Targeting of MDS & AML Stem Cells with an Antisense Inhibitor of STAT3. (April 2017) - Shastri, A.; Teixeira, M.; Bhattacharya, S.; Ramachandra, N.; Lopez, R.; Ravipati, G.; Bhagat, T.; Choudhary, G.; Bartenstein, M.; Gordon-Mitchell, S.; Pradhan, K.; Pellagatti, A.; et al.